Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fulcrum Therapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
FULC
Nasdaq
2830
www.fulcrumtx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics (NASDAQ:FULC) investors are sitting on a loss of 60% if they invested five years ago
- Jun 28th, 2025 7:29 am
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jun 6th, 2025 2:30 pm
Fulcrum Therapeutics, Inc. (FULC): A Bull Case Theory
- May 29th, 2025 11:17 pm
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
- May 29th, 2025 2:10 pm
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
- May 29th, 2025 6:30 am
Fulcrum Therapeutics to Participate in Upcoming May Conferences
- May 8th, 2025 2:05 pm
Fulcrum Therapeutics Inc (FULC) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions and ...
- May 2nd, 2025 1:03 am
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
- May 1st, 2025 5:00 am
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
- Apr 24th, 2025 6:00 am
We're Interested To See How Fulcrum Therapeutics (NASDAQ:FULC) Uses Its Cash Hoard To Grow
- Apr 8th, 2025 4:13 am
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
- Mar 4th, 2025 2:05 pm
Fulcrum Therapeutics Full Year 2024 Earnings: EPS Misses Expectations
- Feb 26th, 2025 3:31 am
Fulcrum Therapeutics Inc (FULC) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
- Feb 26th, 2025 12:04 am
Fulcrum Therapeutics Announces Recent Business Highlights and Financial ResultsĀ for Fourth Quarter and Full Year 2024
- Feb 25th, 2025 5:00 am
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
- Feb 18th, 2025 2:05 pm
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
- Feb 6th, 2025 2:05 pm
Fulcrum Therapeutics Insider Ups Holding During Year
- Feb 4th, 2025 8:15 am
Fulcrum Therapeutics (NASDAQ:FULC) shareholders have endured a 77% loss from investing in the stock three years ago
- Dec 19th, 2024 10:07 am
Fulcrum Therapeutics (FULC) Upgraded to Buy: Here's Why
- Nov 28th, 2024 10:00 am
Fulcrum Therapeutics to Participate in Upcoming December Conferences
- Nov 26th, 2024 2:05 pm
Scroll